These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34105830)

  • 1. Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
    Solipuram V; Baretti M; Kim AY; Chen LX; Fahrner JA; Gunay-Aygun M; Peng XP; Hardenbergh D; Ferguson A; Griffith P; Wang Y; Brancati M; Gopalakrishna H; Kato T; Shubert C; Laheru D; Yarchoan M
    Hepatology; 2021 Nov; 74(5):2899-2901. PubMed ID: 34105830
    [No Abstract]   [Full Text] [Related]  

  • 2. Curative Treatment of Ornithine Transcarbamylase Deficiency With a Liver Transplant: A Case Report.
    Shamsaeefar A; Nikeghbalian S; Dehghani SM; Kazemi K; Motazedian N; Geramizadeh B; Malekhosseini SA
    Exp Clin Transplant; 2019 Feb; 17(1):119-120. PubMed ID: 27447480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
    Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K
    Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410
    [No Abstract]   [Full Text] [Related]  

  • 4. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
    Chan JS; Harding CO; Blanke CD
    South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma].
    Berger C; Dimant P; Hermida L; Paulin F; Pereyra M; Tejo M
    Medicina (B Aires); 2012; 72(5):425-7. PubMed ID: 23089120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
    Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
    Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hyperammonemic encephalopathy due to a portosystemic shunt in a non-cirrhotic adult patient.
    Fuster-Cabré M; Ezquerro-Sáenz S; Requena-Calleja MÁ; Medrano-Peña J; Lapetra-Labé AM
    J Crit Care; 2019 Oct; 53():59-61. PubMed ID: 31195157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
    Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
    Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma.
    Narita R; Kotoh K; Yoneda A; Motomura M; Harada M
    Anticancer Res; 2020 Sep; 40(9):5271-5276. PubMed ID: 32878816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic encephalopathy and orotic aciduria associated with hepatocellular carcinoma in a noncirrhotic liver.
    Jeffers LJ; Dubow RA; Zieve L; Reddy KR; Livingstone AS; Neimark S; Viamonte M; Schiff ER
    Hepatology; 1988; 8(1):78-81. PubMed ID: 2828214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
    Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
    Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
    Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
    Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing Hyperammonemia in Neuroendocrine Tumors.
    Broadbridge V; Townsend A; Pittman K; Kimber R; Patterson W; Sukumaran S; Price TJ
    J Clin Gastroenterol; 2010 Sep; 44(8):e186-9. PubMed ID: 20453660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in hepatology--transplantation, prognosis and imaging.
    Kumar P
    Br J Hosp Med; 1995 Feb 1-14; 53(3):68-9. PubMed ID: 7728318
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of venous blood ammonia in patients with out-of-hospital cardiac arrest.
    Kasai A; Nagao K; Kikushima K; Watanabe K; Tachibana E; Soga T; Matsuzaki M; Yagi T
    Circ J; 2012; 76(4):891-9. PubMed ID: 22313800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 73-Year-Old Woman With Hyperammonemic Encephalopathy Caused by Noncirrhotic Congenital Portosystemic Shunts.
    Yang T; Cheng Y; Deng Z; Lai Y
    Neurology; 2021 Aug; 97(7):340-341. PubMed ID: 34039719
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute Onset Hyperammonemic Encephalopathy Related to Fibrolamellar Carcinoma: Another One Bites the Dust.
    Surjan RCT; Silveira SP; Pinheiro JLS; Pinheiro PHS; Barros MFA; Soares SRP
    Am J Med Sci; 2020 Apr; 359(4):242-244. PubMed ID: 32014302
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
    Ishikawa T; Endo S; Imai M; Azumi M; Nozawa Y; Sano T; Iwanaga A; Honma T; Yoshida T
    Intern Med; 2020; 59(20):2465-2469. PubMed ID: 33055469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemic encephalopathy in a patient with ureterosigmoidostomy and acute hepatitis: a specific case of fulminant hepatic failure.
    Ohnishi S; Yoshida T; Makiyama H; Usui K; Kudo M; Kobayashi T; Hige S; Asaka M
    Dig Dis Sci; 2003 Apr; 48(4):821-3. PubMed ID: 12741478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.